RxDoctor Payments Data

Sravisht Iyer

Orthopaedic Surgery of the Spine · New York, NYNPI 1326338013

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 85.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $37,898 and has fallen 63.0% since, to $14,017 in 2025.

$130,831in general payments, 2019–2025

Across 148 payments — averaging $883.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$112K
  • Stryker$7K
  • Innovasis Inc$3K
  • Medtronic$3K
  • Integrity Implants Inc.$1K
  • Intrinsic Therapeutics$1K
  • plus $4K from 13 others

What the payments were for

  • Consulting fees$43,15033%
  • Speaking & faculty fees$67,75052%
  • Travel & lodging$14,68611%
  • Food & beverage$4,9884%
  • Gifts$380%
  • Entertainment$2180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Globus Medical(2 entities)94$112,145
Stryker10$6,520
Innovasis Inc3$2,917
Medtronic(2 entities)6$2,850
Integrity Implants Inc.8$1,110
Intrinsic Therapeutics2$1,025
Spineguard, Inc.2$1,000
Alphatec Spine, Inc9$771
Bioventus LLC1$750
Augmedics Inc.2$456
Suvon Surgical LLC3$339
Curiteva, Inc.1$218
Arthrex1$145
4web, Inc.1$141
Zimmer Biomet1$124
Seaspine Orthopedics Corporation1$118
Spinal Simplicity, LLC1$97
Medicrea USA, Corp.1$64
Theradaptive, Inc.1$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$130,831 in reported general payments places this provider in the 85th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$270,186
Medicare patients
262
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam12$83

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →